Research Article
Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma
Table 3
Clinicopathological characteristics of FUSCC PDAC patients stratified by MUC5AC expression.
| | Variables | MUC5AC negative | MUC5AC positive | |
| | Age, (%) | | | 0.486 | | <62 | 20 (42.6%) | 175 (47.9%) | | | ≥62 | 27 (57.4%) | 190 (52.1%) | | | Sex, (%) | | | 0.145 | | Male | 32 (68.1%) | 205 (56.9%) | | | Female | 15 (31.9%) | 155 (43.1%) | | | Tumour grade, (%) | | | 0.120 | | Low | 0 (0.0%) | 19 (5.3%) | | | Moderate | 26 (55.3%) | 220 (61.3%) | | | High | 21 (44.7%) | 120 (33.4%) | | | Tumour stage, (%) | | | 0.067 | | I | 19 (40.4%) | 146 (40.0%) | | | II | 27 (57.4%) | 170 (46.6%) | | | III | 1 (2.1%) | 49 (13.4%) | | | T stage, (%) | | | 0.958 | | T1 | 8 (17.0%) | 63 (17.3%) | | | T2 | 28 (59.6%) | 210 (57.5%) | | | T3 | 11 (23.4%) | 92 (25.2%) | | | N stage, (%) | | | 0.084 | | N0 | 21 (44.7%) | 189 (52.5%) | | | N1 | 24 (51.1%) | 130 (36.1%) | | | N2 | 2 (4.3%) | 41 (11.4%) | | | Tumour location, (%) | | | 0.058 | | Head | 20 (42.6%) | 203 (55.6%) | | | Body | 26 (55.3%) | 156 (43.3%) | | | Tail | 1 (2.1%) | 1 (0.3%) | | | Vascular invasion, (%) | | | 0.345 | | No | 10 (21.3%) | 100 (27.8%) | | | Yes | 37 (78.7%) | 260 (72.2%) | | | Perineural infiltration, (%) | | | 0.354 | | No | 39 (83.0%) | 316 (87.8%) | | | Yes | 8 (17.0%) | 44 (12.2%) | | | Diabetes mellitus, (%) | | | 0.097 | | No | 36 (76.6%) | 309 (85.8%) | | | Yes | 11 (23.4%) | 51 (14.2%) | |
|
|
